FL S1006

Creates s. 383.146, F.S. requiring all newborns in Florida hospitals and licensed birth centers to be screened for critical congenital heart disease using pulse oximetry prior to discharge by October 1, 2012.

Allows parents or legal guardians to object to newborn screening; if objection occurs, physician or midwife must document the refusal with a signed written objection from the parent or guardian.

Requires each hospital to designate a lead physician and each licensed birth center to designate a licensed health care provider to oversee newborn congenital heart disease screening programs and ensure appropriate referrals following positive results.

Amends prescription drug distribution laws to create exemptions from permitting requirements for: active pharmaceutical ingredients distributed to in-state manufacturers for finished dosage form preparation; limited quantities of prescription drugs for research, development, teaching, or testing; and intracompany transfers between wholesale distributors operating under the same business name.

Authorizes restricted prescription drug distributors that are health care entities to repackage and distribute prescription drugs to hospitals or other health care entities under common control without requiring a separate repackager permit.